Francesco Passamonti

University of Insubria of Varese, Italy

Francesco Passamonti, MD
Hematology, Department of Medicine and Surgery
University of Insubria, Varese, Italy

Prof. Francesco Passamonti is Full Professor of Hematology at the University of Insubria, Varese, Italy, and Head of the Division of Hematology of Varese. He obtained his medical degree from the University of Pavia, subsequently becoming a specialist in hematology. He worked as Assistant Professor of Hematology at the University of Pavia and as a hematologist at the Hematology of the I.R.C.C.S. Policlinico San Matteo, Pavia, Italy.
He is principal investigator for many clinical trials in hematologic malignancies; however, his main area of interest is in the Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) polycythemia
vera, essential thrombocythemia, and myelofibrosis. He collaborated on the definition of the molecular basis of MPNs and then designed translational studies to evaluate clinical implications of new molecular
discoveries. He designed new prognostic models for essential thrombocythemia and primary and secondary myelofibrosis. He leads and with his group perform many clinical trials on the development of
targeted therapies in MPNs. He participated as a panelist in the definitions of diagnostic criteria, response to treatments, and guidelines for treatment decision. He is a member of the board of the International Working Group on Myeloproliferative Research and Treatment, as well as the European LeukemiaNet Work Package 9 for MPN and the Working Party for MPN of GIMEMA. Prof. Passamonti is a member of several hematology societies and the Editorial Board of the American Journal of Hematology and is an
invited speaker to several international meetings. He has authored and coauthored more than 240 articles on MPN and other hematological malignancies, reaching an h-index of 65 (Scopus, Dec2020).